Literature DB >> 30315879

The Stress c-Jun N-terminal Kinase Signaling Pathway Activation Correlates with Synaptic Pathology and Presents A Sex Bias in P301L Mouse Model of Tauopathy.

Lucia Buccarello1, Clara Alice Musi2, Arianna Turati2, Tiziana Borsello3.   

Abstract

Pathological Tau (P-Tau) leads to dementia and neurodegeneration in tauopathies, including Alzheimer's disease. The P301L transgenic mice well mimic human tauopathy features; P-Tau localizes also at the dendritic spine level and this correlates with synaptic markers down-regulation. Importantly, tg females present a more severe pathology compared to male mice. We describe JNK activation in P301L-tg mice, characterizing by P-JNK and P-c-Jun, cleaved-Caspase-3, P-PSD95 and P-Tau (direct JNK-targets) increased levels in tg vs control mice. These data indicate that JNK stress pathway is involved in neuronal degenerative mechanisms of this mouse model. In addition, P-JNK level is higher in females compared to male tg mice, underlying a sexual dimorphism in the JNK pathway activation. The behavioral studies highlight that tg females present major cognitive and locomotor defects, strongly correlated with a more severe synaptic injury, in comparison to tg male. Notably, at the dendritic spine level, JNK is powerfully activated and its level reveals a sexual dimorphism that is coherent with behavioral defects and spine pathology. The P301L's synaptic pathology is characterized by a strong increase of P-PSD95/PSD95 and P-JNK/JNK ratios and by an augmented level of cleaved-Caspase-3 and a decrease of Drebrin level in the post-synaptic elements. These results suggest that JNK plays a key role in synaptopathy of P301L mice. Importantly, until now, there are any efficient treatments against synaptic pathology and JNK could represent an interesting target to tackle P-Tau-induced synaptic pathology. It will be important to test specific JNK inhibitors to verify their potential neuroprotective effect.
Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drebrin; P-Tau protein; behavioral defects; cleaved-caspase-3; synaptic dysfunction; synaptopathy

Mesh:

Substances:

Year:  2018        PMID: 30315879     DOI: 10.1016/j.neuroscience.2018.09.049

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  3 in total

1.  Impact of JNK and Its Substrates on Dendritic Spine Morphology.

Authors:  Emilia Komulainen; Artemis Varidaki; Natalia Kulesskaya; Hasan Mohammad; Christel Sourander; Heikki Rauvala; Eleanor T Coffey
Journal:  Cells       Date:  2020-02-14       Impact factor: 6.600

2.  JNK signaling provides a novel therapeutic target for Rett syndrome.

Authors:  Clara Alice Musi; Anna Maria Castaldo; Anna Elisa Valsecchi; Sara Cimini; Noemi Morello; Riccardo Pizzo; Alessandra Renieri; Ilaria Meloni; Maurizio Bonati; Maurizio Giustetto; Tiziana Borsello
Journal:  BMC Biol       Date:  2021-12-16       Impact factor: 7.431

3.  The Mechanism of TNF-α-Mediated Accumulation of Phosphorylated Tau Protein and Its Modulation by Propofol in Primary Mouse Hippocampal Neurons: Role of Mitophagy, NLRP3, and p62/Keap1/Nrf2 Pathway.

Authors:  Lin Zhang; Hong Song; Jie Ding; Dong-Jie Wang; Shi-Peng Zhu; Chi Liu; Xian Jin; Jia-Wei Chen
Journal:  Oxid Med Cell Longev       Date:  2022-08-12       Impact factor: 7.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.